Sfoglia per AUTORE
PALUMBO G
Collezione AOU Novara

  

Items : 15

Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials. in Haematologica / Haematologica. 2024 Jan 1;109(1):245-255. doi: 10.3324/haematol.2023.283251.

2024
AOU Città della Salute di Torino
AOU Novara

Morabito F; Neri A; Di Raimondo F; Petrucci MT; Nappi D; Bertuglia G; Ferretti E; Sgherza N; Rizzi R; Cotzia E; Gozzetti A; Bongarzoni V; Rossini B; Fontana R; Accardi F; Amico V; Amendola A; Vincelli D; Brunori M; Palumbo G; Pompa A; Uccello G; Barilà G; Casaluci GM; Rago A; Ria R; Tarantini G; Offidani M; Cerchione C; et alii...

Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMA. in HemaSphere / Hemasphere. 2023 Aug 30;7(9):e944. doi: 10.1097/HS9.0000000000000944. eCollection 2023 Sep.

2023
AOU Novara
AOU Città della Salute di Torino

Vallisa D; Invernizzi R; Lemoli RM; Fedele M; Sarlo C; Capodanno I; Frairia C; Fianchi L; Voso MT; Baron F; Petranovic D; Ricco A; Stauder R; Luppi M; Breccia M; Cottone F; Caocci G; Palumbo GA; Niscola P; Platzbecker U; Al Essa W; Efficace F; Di Renzo N; Fozza C; Doro M; Giesinger JM; Vignetti M;

Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS). in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2023 Oct 1;41(28):4486-4496. doi: 10.1200/JCO.22.02699. Epub 2023 Jun 9.

2023
ASL Biella
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Latagliata R; Zini G; Rizzo L; Bova I; D'Errigo MG; Cufari P; Arcadi MT; Delfino IM; Liberati AM; Candoni A; Rivellini F; Buccisano F; Stamatoullas-Bastard A; Ricco A; Palumbo GA; Impera S; Di Renzo N; Fenaux P; Germing U; Molteni A; Bocchia M; Beltrami G; Russo E; Castelli A; Fattizzo B; Guarini A; Tripepi G; Iannì G; Reda G; et alii...

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial. in Blood advances / Blood Adv. 2023 Jul 25;7(14):3764-3774. doi: 10.1182/bloodadvances.2022009504.

2023
AO Cuneo
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Cortelazzo S; Galimberti S; Palumbo GA; Puccini B; Ferreri AJM; Ballerini F; Lucchini E; Arcaini L; Moita F; Zilioli V; Balzarotti M; Boccomini C; Stefoni V; Cavallo F; Re A; Di Rocco A; Tavarozzi R; Ghislieri M; De Luca G; Zaccaria GM; Alessandria B; Genuardi E; Pironti M; Grimaldi D; Arrigoni E; Ferrero S; Di Paolo A; Ladetto M;

Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study. in British journal of haematology / Br J Haematol. 2022 Apr;197(2):190-200. doi: 10.1111/bjh.18057. Epub 2022 Feb 8.

2022
AOU Città della Salute di Torino
AOU Novara

Caramella M; Cilloni D; Latagliata R; Palandri F; Abruzzese E; Bonifacio M; Palumbo GA; Gambacorti-Passerini C; Breccia M; Bucelli C; Scaffidi L; Biale L; Cattaneo D; Trawinska MM; Auteri G; Markovic U; Renso R; Crisà E; Porrini R; Caocci G; Pugliese N; Polverelli N; Tiribelli M; Bergamaschi M; Benevolo G; Carmosino I; Bartoletti D; Iurlo A; Di Veroli A; et alii...

The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index. in Leukemia / Leukemia. 2020 Sep;34(9):2451-2459. doi: 10.1038/s41375-020-0746-8. Epub 2020 Feb 21.

2020
AOU Città della Salute di Torino
AOU Novara

Capodanno I; Frairia C; Fianchi L; Luppi M; Petranovic D; Caers J; Ricco A; Stauder R; Caocci G; Palumbo GA; Platzbecker U; Breccia M; Niscola P; Patriarca A; Cella D; Oswald LB; Cottone F; Efficace F; Follini E; Sarlo C; Fazi P; Vignetti M;

SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience. in HemaSphere / Hemasphere. 2020 Sep 23;4(5):e483. doi: 10.1097/HS9.0000000000000483. eCollection 2020 Oct.

2020
ASL Torino 5
ASL Biella
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
ASL Città di Torino
ASL Torino 4
AO Alessandria
AOU Novara

Santini V; Tafuri A; Selleri C; Rivellini F; Secchi R; Sciumé M; Sarlo C; Riva M; Poloni A; Pilo F; Pelizzari A; Palumbo GA; Musto P; Oliva E; Messa E; Niscola P; Molteni A; Mancini S; Frattini F; Gaidano V; Guaragna G; Latagliata R; Gumenyuk S; Finelli C; Giai V; Fianchi L; Filì C; Ferrara IL; Fava C; et alii...

High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity. in International journal of hematology / Int J Hematol. 2020 Aug;112(2):141-146. doi: 10.1007/s12185-020-02920-y. Epub 2020 Jun 25.

2020
AOU Novara

Caocci G; Vignetti M; Patriarca A; Breccia M; Platzbecker U; Palumbo GA; Stauder R; Cottone F; Petranovic D; Voso MT; Tafuri A; Invernizzi R; Caers J; Luppi M; La Nasa G; Niscola P; Efficace F;

The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib. in British journal of haematology / Br J Haematol. 2018 Sep;182(5):701-704. doi: 10.1111/bjh.15450. Epub 2018 Jul 9.

2018
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Boccadoro M; Mezzabotta M; Marchetti M; Lanzarone G; Cerrano M; Frairia C; Beggiato E; Pugliese N; Elli EM; Martinelli V; Palumbo GA; Cilloni D; Ferrero D; Crisà E;

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes. in Cancer / Cancer. 2018 Mar 15;124(6):1251-1259. doi: 10.1002/cncr.31193. Epub 2017 Dec 12.

2018
AOU Novara

Efficace F; Cottone F; Abel G; Niscola P; Gaidano G; Bonnetain F; Anota A; Caocci G; Cronin A; Fianchi L; Breccia M; Stauder R; Platzbecker U; Palumbo GA; Luppi M; Invernizzi R; Bergamaschi M; Borin L; Di Tucci AA; Zhang H; Sprangers M; Vignetti M; Mandelli F;

Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide. in Leukemia & lymphoma / Leuk Lymphoma. 2018 Feb;59(2):423-433. doi: 10.1080/10428194.2017.1339872. Epub 2017 Jun 22.

2018
AOU Novara

Maffei R; Fiorcari S; Martinelli S; Benatti S; Bulgarelli J; Rizzotto L; Debbia G; Santachiara R; Rigolin GM; Forconi F; Rossi D; Laurenti L; Palumbo GA; Vallisa D; Cuneo A; Gaidano G; Luppi M; Marasca R;

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study. in The Lancet. Oncology / Lancet Oncol. 2015 Nov;16(15):1506-1514. doi: 10.1016/S1470-2045(15)00206-5. Epub 2015 Sep 21.

2015
AOU Novara

Efficace F; Gaidano G; Breccia M; Voso MT; Cottone F; Angelucci E; Caocci G; Stauder R; Selleslag D; Sprangers M; Platzbecker U; Ricco A; Sanpaolo G; Beyne-Rauzy O; Buccisano F; Palumbo GA; Bowen D; Nguyen K; Niscola P; Vignetti M; Mandelli F;

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes. in Leukemia research / Leuk Res. 2015 Aug;39(8):859-65. doi: 10.1016/j.leukres.2015.05.012. Epub 2015 Jun 12.

2015
AOU Novara

Caocci G; Voso MT; Angelucci E; Stauder R; Cottone F; Abel G; Nguyen K; Platzbecker U; Beyne-Rauzy O; Gaidano G; Invernizzi R; Molica S; Criscuolo M; Breccia M; Lübbert M; Sanpaolo G; Buccisano F; Ricco A; Palumbo GA; Niscola P; Zhang H; Fenu S; La Nasa G; Mandelli F; Efficace F;

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study. in Haematologica / Haematologica. 2015 Apr;100(4):517-24. doi: 10.3324/haematol.2014.108183. Epub 2015 Jan 16.

2015
AOU Novara

Rossi D; Bruscaggin A; La Cava P; Galimberti S; Ciabatti E; Luminari S; Rigacci L; Tucci A; Pulsoni A; Bertoldero G; Vallisa D; Rusconi C; Spina M; Arcaini L; Angrilli F; Stelitano C; Merli F; Gaidano G; Federico M; Palumbo GA;

Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia. in Experimental hematology / Exp Hematol. 2014 Feb;42(2):126-36.e1. doi: 10.1016/j.exphem.2013.10.007. Epub 2013 Nov 6.

2014
AOU Novara

Maffei R; Fiorcari S; Bulgarelli J; Rizzotto L; Martinelli S; Rigolin GM; Debbia G; Castelli I; Bonacorsi G; Santachiara R; Forconi F; Rossi D; Laurenti L; Palumbo GA; Vallisa D; Cuneo A; Gaidano G; Luppi M; Marasca R;